tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AbbVie Advances Obesity Pipeline With Completion of First-in-Human GUB014295 Trial
PremiumCompany AnnouncementsAbbVie Advances Obesity Pipeline With Completion of First-in-Human GUB014295 Trial
3d ago
AbbVie Quietly Advances ABBV‑CLS‑616: What a Completed Phase 1 Trial Signals for Investors
Premium
Company Announcements
AbbVie Quietly Advances ABBV‑CLS‑616: What a Completed Phase 1 Trial Signals for Investors
3d ago
3 Best Dividend Aristocrat Stocks to Buy Now, 01/15/2026
Premium
Market News
3 Best Dividend Aristocrat Stocks to Buy Now, 01/15/2026
3d ago
AbbVie, RemeGen announce exclusive licensing agreement for RC148
PremiumThe FlyAbbVie, RemeGen announce exclusive licensing agreement for RC148
6d ago
West Pharmaceutical to sell SmartDose 3.5mL rights to AbbVie for $112.5M
Premium
The Fly
West Pharmaceutical to sell SmartDose 3.5mL rights to AbbVie for $112.5M
6d ago
AbbVie to acquire Arizona manufacturing facility, IP from West Pharmaceutical
Premium
The Fly
AbbVie to acquire Arizona manufacturing facility, IP from West Pharmaceutical
6d ago
M&A News: Revolution Medicines (RVMD) Stock Rallies on News of Potential Acquisition by Merck
PremiumMarket NewsM&A News: Revolution Medicines (RVMD) Stock Rallies on News of Potential Acquisition by Merck
9d ago
AbbVie Advances Icalcaprant Trial in Depression: What Investors Should Watch
Premium
Company Announcements
AbbVie Advances Icalcaprant Trial in Depression: What Investors Should Watch
10d ago
AbbVie’s Real‑World Upadacitinib Study in Japan Wraps Up, Setting the Stage for New Atopic Dermatitis Insights
Premium
Company Announcements
AbbVie’s Real‑World Upadacitinib Study in Japan Wraps Up, Setting the Stage for New Atopic Dermatitis Insights
10d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100